Mostrar el registro sencillo del ítem
| dc.contributor.author | Lip, Gregory-Y-H | |
| dc.contributor.author | Hammerstingl, Christoph | |
| dc.contributor.author | Marín, Francisco | |
| dc.contributor.author | Cappato, Riccardo | |
| dc.contributor.author | Meng, Isabelle-Ling | |
| dc.contributor.author | van-Eickels, Martin | |
| dc.contributor.author | Kirsch, Bodo | |
| dc.contributor.author | Cohen, Ariel | |
| dc.date.accessioned | 2026-10-21T06:05:20Z | |
| dc.date.available | 2026-10-21T06:05:20Z | |
| dc.date.issued | 2016-08 | |
| dc.identifier.citation | Lip GYH, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, et al. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). American Heart Journal. agosto de 2016;178:126-34. doi:10.1016/j.ahj.2016.05.007 | |
| dc.identifier.issn | 0002-8703 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/28691 | |
| dc.description.abstract | BACKGROUND: Data on left atrial/left atrial appendage (LA/LAA) thrombus resolution after non-vitamin K antagonist (VKA) oral anticoagulant treatment are scarce. The primary objective of X-TRA was to explore the use of rivaroxaban for the resolution of LA/LAA thrombi in patients with nonvalvular atrial fibrillation (AF) or atrial flutter, with the CLOT-AF registry providing retrospective data after standard-of-care therapy in this setting. METHODS: X-TRA was a prospective, single-arm, open-label, multicenter study that investigated rivaroxaban treatment for 6 weeks for LA/LAA thrombus resolution in patients with nonvalvular AF or atrial flutter and LA/LAA thrombus confirmed at baseline on a transesophageal echocardiogram (TEE). CLOT-AF retrospectively collected thrombus-related patient outcome data after standard-of-care anticoagulant treatment for 3 to 12 weeks in patients with nonvalvular AF or atrial flutter who had LA/LAA thrombi on TEE recorded in their medical file. RESULTS: In X-TRA, patients were predominantly (95.0%) from Eastern European countries. The adjudicated thrombus resolution rate was 41.5% (22/53 modified intention-to-treat [mITT] patients, 95% CI 28.1%-55.9%) based on central TEE assessments. Resolved or reduced thrombus was evident in 60.4% (32/53 mITT patients, 95% CI 46.0%-73.6%) of patients. In CLOT-AF, the reported thrombus resolution rate was 62.5% (60/96 mITT patients, 95% CI 52.0%-72.2%) and appeared better in Western European countries (34/50; 68.0%) than in Eastern European countries (26/46; 56.5%). CONCLUSION: X-TRA is the first prospective, multicenter study examining LA/LAA thrombus resolution with a non-VKA oral anticoagulant in VKA-naïve patients or in patients with suboptimal VKA therapy. Rivaroxaban could be a potential option for the treatment of LA/LAA thrombi. | |
| dc.language.iso | eng | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Aged, 80 and over | |
| dc.subject.mesh | Atrial Appendage | |
| dc.subject.mesh | Atrial Fibrillation/complications | |
| dc.subject.mesh | Atrial Flutter/complications | |
| dc.subject.mesh | Echocardiography, Transesophageal | |
| dc.subject.mesh | Factor Xa Inhibitors/therapeutic use | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Heart Atria | |
| dc.subject.mesh | Heart Diseases/diagnostic imaging/drug therapy/etiology | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Prospective Studies | |
| dc.subject.mesh | Registries | |
| dc.subject.mesh | Retrospective Studies | |
| dc.subject.mesh | Rivaroxaban/therapeutic use | |
| dc.subject.mesh | Thrombosis/diagnostic imaging/drug therapy/etiology | |
| dc.title | Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 27502860 | |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S0002870316300643 | |
| dc.identifier.doi | 10.1016/j.ahj.2016.05.007 | |
| dc.journal.title | American Heart Journal | |
| dc.identifier.essn | 1097-5330 |